Gina M. Wallar - 31 Dec 2021 Form 5 Insider Report for NEOGENOMICS INC (NEO)

Role
President, Pharma Services
Signature
/s/ Gina M. Wallar
Issuer symbol
NEO
Transactions as of
31 Dec 2021
Net transactions value
+$12,807
Form type
5
Filing time
08 Feb 2022, 18:12:21 UTC
Previous filing
30 Dec 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Small acquisition under Rule 16a-6 $12,807 +363 +1.7% $35.28 21,662 31 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 6,667 31 Dec 2021 Common Stock 6,667 $9.22 Direct F2
holding NEO Stock Option (Right to Buy) 8,334 31 Dec 2021 Common Stock 8,334 $13.87 Direct F3
holding NEO Stock Option (Right to Buy) 7,153 31 Dec 2021 Common Stock 7,153 $20.83 Direct F4
holding NEO Stock Option (Right to Buy) 7,879 31 Dec 2021 Common Stock 7,879 $27.34 Direct F5
holding NEO Stock Option (Right to Buy) 8,595 31 Dec 2021 Common Stock 8,595 $48.99 Direct F6
holding NEO Stock Option (Right to Buy) 10,126 31 Dec 2021 Common Stock 10,126 $43.95 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3.
F2 On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F3 On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F4 On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5 On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6 On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7 On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date.